Predicting long‐term clinical stability in amyloid‐positive subjects by FDG‐PET

Predicting long‐term clinical stability in amyloid‐positive subjects by FDG‐PET

Abstract Imaging biomarkers can be used to screen participants for Alzheimer's disease clinical trials. To test the predictive values in clinical progression of neuropathology change (amyloid‐PET) or brain metabolism as neurodegeneration biomarker ([18F]FDG‐PET), we evaluated data from N = 268...

Full description

Bibliographic Details
Main Authors:	Leonardo Iaccarino, Arianna Sala, Daniela Perani, the Alzheimer's Disease Neuroimaging Initiative
Format:	Article
Language:	English
Published:	Wiley 2019-06-01
Series:	Annals of Clinical and Translational Neurology
Online Access:	https://doi.org/10.1002/acn3.782

Similar Items

FDG-PET hypermetabolism is associated with higher tau-PET in mild cognitive impairment at low amyloid-PET levels
by: Anna Rubinski, et al.
Published: (2020-10-01)

A Survey of FDG- and Amyloid-PET Imaging in Dementia and GRADE Analysis
by: Perani Daniela, et al.
Published: (2014-01-01)

Classification of Alzheimer’s and MCI Patients from Semantically Parcelled PET Images: A Comparison between AV45 and FDG-PET
by: Seyed Hossein Nozadi, et al.
Published: (2018-01-01)

Erratum to “A Survey of FDG- and Amyloid-PET Imaging in Dementia and GRADE Analysis”
by: Daniela Perani, et al.
Published: (2014-01-01)

Deep learning-based amyloid PET positivity classification model in the Alzheimer’s disease continuum by using 2-[18F]FDG PET
by: Suhong Kim, et al.
Published: (2021-06-01)

Classification of Alzheimer’s Disease by Combination of Convolutional and Recurrent Neural Networks Using FDG-PET Images
by: Manhua Liu, et al.
Published: (2018-06-01)

The emerging role of PET imaging in dementia [version 1; referees: 3 approved]
by: Leonardo Iaccarino, et al.
Published: (2017-10-01)

Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach
by: Sarah K. Royse, et al.
Published: (2021-05-01)

Development and evaluation of an automated quantification tool for amyloid PET images
by: Yuma Tsubaki, et al.
Published: (2020-09-01)

Predicting MCI progression with FDG-PET and cognitive scores: a longitudinal study
by: Lirong Teng, et al.
Published: (2020-04-01)

Generative FDG-PET and MRI model of aging and disease progression in Alzheimer's disease.
by: Juergen Dukart, et al.
Published: (2013-04-01)

Data-driven FDG-PET subtypes of Alzheimer’s disease-related neurodegeneration
by: Fedor Levin, et al.
Published: (2021-02-01)

Low-dose CT for the spatial normalization of PET images: A validation procedure for amyloid-PET semi-quantification
by: Luca Presotto, et al.
Published: (2018-01-01)

A FDG-PET Study of Metabolic Networks in Apolipoprotein E ε4 Allele Carriers.
by: Zhijun Yao, et al.
Published: (2015-01-01)

Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer’s disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database
by: Fayçal Ben Bouallègue, et al.
Published: (2017-04-01)

Levels of Cortisol in CSF Are Associated With SNAP-25 and Tau Pathology but Not Amyloid-β
by: Qing Wang, et al.
Published: (2018-11-01)

FDG-PET as an independent biomarker for Alzheimer’s biological diagnosis: a longitudinal study
by: Ya-Nan Ou, et al.
Published: (2019-06-01)

Multimodal neuroimaging study of cerebrovascular disease, amyloid deposition, and neurodegeneration in Alzheimer's disease progression
by: Patrick J. Lao, et al.
Published: (2018-01-01)

Study of the Influence of Age in 18F-FDG PET Images Using a Data-Driven Approach and Its Evaluation in Alzheimer’s Disease
by: Jiehui Jiang, et al.
Published: (2018-01-01)

Moderating effects of sex on the impact of diagnosis and amyloid positivity on verbal memory and hippocampal volume
by: Jessica Z. K. Caldwell, et al.
Published: (2017-09-01)

PET Neuroimaging: Insights on Dystonia and Tourette syndrome and potential applications
by: Pierpaolo eAlongi, et al.
Published: (2014-09-01)

Voxel-based statistical analysis and quantification of amyloid PET in the Japanese Alzheimer’s disease neuroimaging initiative (J-ADNI) multi-center study
by: Go Akamatsu, et al.
Published: (2019-09-01)

Added value of amyloid PET in individualized risk predictions for MCI patients
by: Ingrid S. vanMaurik, et al.
Published: (2019-12-01)

The temporal relationships between white matter hyperintensities, neurodegeneration, amyloid beta, and cognition
by: Mahsa Dadar, et al.
Published: (2020-01-01)

Protective Factors Modulate the Risk of Beta Amyloid in Alzheimer’s Disease
by: Bin Zhou, et al.
Published: (2020-01-01)

Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease
by: Hákon Valur Dansson, et al.
Published: (2021-09-01)

Data analysis with Shapley values for automatic subject selection in Alzheimer’s disease data sets using interpretable machine learning
by: Louise Bloch, et al.
Published: (2021-09-01)

Brain Molecular Connectivity in Neurodegenerative Diseases: Recent Advances and New Perspectives Using Positron Emission Tomography
by: Arianna Sala, et al.
Published: (2019-06-01)

Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer’s disease
by: Marion Ortner, et al.
Published: (2019-10-01)

Brain Entropy Mapping in Healthy Aging and Alzheimer’s Disease
by: Ze Wang, et al.
Published: (2020-11-01)

Practical algorithms for amyloid β probability in subjective or mild cognitive impairment
by: Nancy Maserejian, et al.
Published: (2019-12-01)

The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory
by: Nicolai Franzmeier, et al.
Published: (2019-04-01)

Gender Differences in Elderly With Subjective Cognitive Decline
by: Lijun Wang, et al.
Published: (2018-06-01)

Correction to: Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer’s disease
by: Marion Ortner, et al.
Published: (2020-03-01)

Multimodality Imaging Approaches in Alzheimer's disease. Part II: 1H MR spectroscopy, FDG PET and Amyloid PET
by: Chetsadaporn Promteangtrong, et al.

Network interdigitations of Tau and amyloid-beta deposits define cognitive levels in aging
by: Alzheimer's Disease Neuroimaging Initiative (ADNI), et al.
Published: (2021)

PET-FDG: Impetus
by: Cristina Nanni
Published: (2020-04-01)

Amyloid biomarkers as predictors of conversion from mild cognitive impairment to Alzheimer’s dementia: a comparison of methods
by: Arnd Sörensen, et al.
Published: (2020-11-01)

False-positive FDG PET CT Scan in Vertebral Hemangioma
by: Shrikant Solav, et al.
Published: (2019-01-01)

Suture Granuloma Showing False-Positive Findings on FDG-PET
by: Kohei Takahara, et al.
Published: (2013-01-01)